News Novo's next-gen diabetes drug could be best at cutting heart... Novo boosted by results from next-gen GLP-1.
Debates & Insight Sponsored Patient centricity: Identifying how Boehringer Ingelheim UK ... Boehringer Ingelheim UK provides an update on its patient centricity initiative ahead of a new white paper later this year.
News Boehringer and Qualcomm collaborate on digital COPD inhaler New connected inhaler will attempt to address low adherence rates.
News Bad news for Sanofi as biosimilar replaces Lantus Pharmacy benefit firm axes Lantus, decision due on key combination therapy.
News Ambrosia's sweet $100m round, and other biofinancings Our latest crop of biofinancings has a nine-figure round for Ambrosia, with Pinnacle Medicines, Immutrin, and Gilgamesh Pharma also raising new funds.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
